Literature DB >> 12028454

Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy.

Paisit Paueksakon1, Monica P Revelo, Li-Jun Ma, Carmelita Marcantoni, Agnes B Fogo.   

Abstract

BACKGROUND: Microvascular injury and mesangial dysfunction contribute to the pathogenesis of diabetic glomerulosclerosis. We investigated the extent of microvascular injury characterized by fragmented red blood cells (RBCs) in the mesangium of glomeruli in diabetic nephropathy, and its clinicopathologic significance. We also investigated the possible contributions of plasminogen activator inhibitor-1 (PAI-1), which has been implicated in thrombosis and sclerosis, and the novel steroid receptor superfamily member, peroxisome proliferator-activated receptorgamma (PPARgamma), implicated in monocyte-foamy macrophage transformation in atherosclerosis and improved insulin responsiveness in diabetes.
METHODS: Sixty-four diabetic nephropathy (DN) cases in our renal biopsy files at VUMC, diagnosed between 1997 and 1999, were reviewed. Patients were classified based on the presence or absence of fragmented RBCs in the mesangium (M+, M-). PAI-1 and PPARgamma immunostaining was performed with double staining for the macrophage marker CD68.
RESULTS: M+ lesions were present in 21.9% of cases, and in positive cases, involved on average 10.2 +/- 2.1% of glomeruli. M+ patients were 40- to 78-years-old (mean +/- SD, 60.4 +/- 9.8), the female/male ratio was 2.5, and the white/black ratio was 6. In M-, the patients' ages ranged from 29 to 81 years (57.6 +/- 13.3, P = NS vs. M+), the female/male ratio was 0.5 (P < 0.05 vs. M+), and the white/black ratio was 2.3 (P = 0.1 vs. M+). Mean 24-hour urine protein in M+ was 9.9 +/- 13.6 g/24 h, versus 4.0 +/- 2.8 g/24 h in M- (P < 0.05). The fragmented RBCs in M+ cases localized exclusively within Kimmelstiel-Wilson nodules. PAI-1 and PPARgamma immunostaining was increased in areas of sclerosis in arteries and glomeruli, with expression of both in glomerular mesangial, parietal and visceral epithelial cells. Infiltrating macrophages in glomeruli were PPARgamma negative, contrasting positivity in macrophages in control cases of carotid artery plaque and in renal interstitial macrophages. The Kimmelstiel-Wilson nodules in M+ patients showed increased PAI-1 staining.
CONCLUSIONS: Mesangial RBC fragments are indicative of microvascular injury and mesangiolysis in DN and are associated with worse proteinuria, and possible worse prognosis. Possible pathogenic mechanisms involve the fibrinolytic/proteolytic system and locally activated PAI-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12028454     DOI: 10.1046/j.1523-1755.2002.00384.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  23 in total

Review 1.  Modulation of glomerulosclerosis.

Authors:  Li-Jun Ma; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2007-09-08       Impact factor: 9.623

Review 2.  PPARγ and chronic kidney disease.

Authors:  Agnes B Fogo
Journal:  Pediatr Nephrol       Date:  2010-07-30       Impact factor: 3.714

3.  A plasminogen activator inhibitor type 1 mutant retards diabetic nephropathy in db/db mice by protecting podocytes.

Authors:  Jiandong Zhang; Chunyan Gu; Daniel A Lawrence; Alfred K Cheung; Yufeng Huang
Journal:  Exp Physiol       Date:  2014-01-17       Impact factor: 2.969

4.  Endothelial cell-specific overexpression of endothelial nitric oxide synthase in Ins2Akita mice exacerbates diabetic nephropathy.

Authors:  Mohan Natarajan; Samy L Habib; Robert L Reddick; Caroline R Delma; Krishnan Manickam; Thomas J Prihoda; Sherry L Werner; Sumathy Mohan
Journal:  J Diabetes Complications       Date:  2018-10-13       Impact factor: 2.852

5.  Fibroblast-specific plasminogen activator inhibitor-1 depletion ameliorates renal interstitial fibrosis after unilateral ureteral obstruction.

Authors:  Lan Yao; M Frances Wright; Brandon C Farmer; Laura S Peterson; Amir M Khan; Jianyong Zhong; Leslie Gewin; Chuan-Ming Hao; Hai-Chun Yang; Agnes B Fogo
Journal:  Nephrol Dial Transplant       Date:  2019-12-01       Impact factor: 5.992

6.  Renal fibrosis: not just PAI-1 in the sky.

Authors:  Agnes B Fogo
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

7.  A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis.

Authors:  Yufeng Huang; Masashi Haraguchi; Daniel A Lawrence; Wayne A Border; Ling Yu; Nancy A Noble
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 8.  The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases.

Authors:  Hunjoo Ha; Eun Y Oh; Hi B Lee
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

9.  17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling.

Authors:  Alexis Dixon; Christine Maric
Journal:  Am J Physiol Renal Physiol       Date:  2007-08-08

10.  Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease.

Authors:  M Lassila; K Fukami; K Jandeleit-Dahm; T Semple; P Carmeliet; M E Cooper; A R Kitching
Journal:  Diabetologia       Date:  2007-04-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.